Clifford Swan Investment Counsel LLC / ABT
Clifford Swan Investment Counsel LLC’s Abbott Laboratories Position
Does Clifford Swan Investment Counsel LLC own Abbott Laboratories (ABT)? Yes — 201.3K shares worth $21M (+0.70% of its 13F portfolio) as of Q1 2026, down from 204.6K shares the prior filed quarter.
Position Value
$21M
Q1 2026
Shares
201.3K
% of Portfolio
+0.70%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 201.3K | $21M | +0.70% |
| Q4 2025 | 204.6K | $26M | +0.85% |
| Q3 2025 | 208.2K | $28M | +0.93% |
| Q2 2025 | 209.3K | $28M | +1.00% |
| Q1 2025 | 212.1K | $28M | +1.04% |
| Q4 2024 | 213.7K | $24M | +0.87% |
| Q3 2024 | 217.8K | $25M | +0.88% |
| Q2 2024 | 221.5K | $23M | +0.86% |
| Q1 2024 | 223.2K | $25M | +0.94% |
| Q4 2023 | 231.7K | $25M | +0.99% |
| Q3 2023 | 232.4K | $23M | +0.94% |
| Q2 2023 | 235.0K | $26M | +1.03% |
| Q1 2023 | 236.6K | $24M | +1.00% |
| Q4 2022 | 240.1K | $26M | +1.15% |
| Q3 2022 | 241.0K | $23M | +1.09% |
| Q2 2022 | 254.4K | $28M | +1.20% |
| Q1 2022 | 255.7K | $30M | +1.12% |
| Q4 2021 | 259.5K | $37M | +1.28% |
| Q3 2021 | 259.6K | $33M | +1.23% |
| Q2 2021 | 259.8K | $32M | +1.20% |
| Q1 2021 | 267.8K | $32M | +1.32% |
| Q4 2020 | 269.7K | $30M | +1.29% |
| Q3 2020 | 272.0K | $30M | +1.42% |
| Q2 2020 | 274.0K | $25M | +1.29% |
| Q1 2020 | 277.1K | $22M | +1.33% |
| Q4 2019 | 280.5K | $24M | +1.18% |
| Q3 2019 | 283.0K | $24M | +1.23% |
| Q2 2019 | 283.6K | $24M | +1.26% |
| Q1 2019 | 291.9K | $23M | +1.25% |
| Q4 2018 | 314.4K | $23M | +1.38% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Clifford Swan Investment Counsel LLC’s full portfolio or all institutional holders of ABT.